CD38 and melanoma: Chen and colleagues have significantly contributed to expanding the knowledge in this field: they have detected up-regulation of CD38 in murine models of lung cancer and melanoma chronically exposed to PD-1/PDL-1 inhibitors, independent of tumor histological type [92].